Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eli Lilly Ropes In Lupin For A Big Push For Its Insulin Brands In India

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - As Pfizer Inc. warms up for an entry into the rapidly growing Indian insulin market, Eli Lilly & Co., which is already established in the Indian market, is looking to strengthen its franchise via a strategic collaboration with Lupin Ltd. - an Indian company making significant strides in the anti-diabetes, cardiology, nephrology and respiratory segments

You may also be interested in...



Emerging Markets Slowdown Trips Up Lilly’s 2014 Revenue Estimates

Lilly says emerging markets represent “clear and significant opportunity” despite recent difficulties.

As India’s Diabetes Market Grows, Eli Lilly Brings In A New Leader

With an eye on diabetes and non-communicable diseases, Lilly taps new leadership in India.

Lessons From Galvus: Novartis Teams Up With India’s Lupin To Market COPD Drug Onbrez

Novartis will compete against market leader Cipla to make a dent in the emerging Indian COPD space.

Related Content

UsernamePublicRestriction

Register

SC078686

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel